Titre : Mépacrine

Mépacrine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Doxycycline
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Mépacrine : Questions médicales les plus fréquentes", "headline": "Mépacrine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Mépacrine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-23", "dateModified": "2025-04-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Mépacrine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Aminoacridines", "url": "https://questionsmedicales.fr/mesh/D000609", "about": { "@type": "MedicalCondition", "name": "Aminoacridines", "code": { "@type": "MedicalCode", "code": "D000609", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.046.250" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Moutarde de quinacrine", "alternateName": "Quinacrine Mustard", "url": "https://questionsmedicales.fr/mesh/D011797", "about": { "@type": "MedicalCondition", "name": "Moutarde de quinacrine", "code": { "@type": "MedicalCode", "code": "D011797", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.300.046.250.760.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Mépacrine", "alternateName": "Quinacrine", "code": { "@type": "MedicalCode", "code": "D011796", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Chanakya Nath Kundu", "url": "https://questionsmedicales.fr/author/Chanakya%20Nath%20Kundu", "affiliation": { "@type": "Organization", "name": "Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha, 751024, India. cnkundu@kiitbiotech.ac.in." } }, { "@type": "Person", "name": "Thomas R Lane", "url": "https://questionsmedicales.fr/author/Thomas%20R%20Lane", "affiliation": { "@type": "Organization", "name": "Collaborations Pharmaceuticals, Inc., Raleigh, North Carolina, USA." } }, { "@type": "Person", "name": "Sean Ekins", "url": "https://questionsmedicales.fr/author/Sean%20Ekins", "affiliation": { "@type": "Organization", "name": "Collaborations Pharmaceuticals, Inc., Raleigh, North Carolina, USA peter.madrid@sri.com sean@collaborationspharma.com." } }, { "@type": "Person", "name": "Biswajit Das", "url": "https://questionsmedicales.fr/author/Biswajit%20Das", "affiliation": { "@type": "Organization", "name": "Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha, 751024, India." } }, { "@type": "Person", "name": "Chinmayee Sethy", "url": "https://questionsmedicales.fr/author/Chinmayee%20Sethy", "affiliation": { "@type": "Organization", "name": "Cancer Biology Division, School of Biotechnology, Kalinga Institute of Industrial Technology (KIIT), Deemed to be University, Campus-11, Patia, Bhubaneswar, Odisha, 751024, India." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Dexamethasone and doxycycline functionalized nanoparticles enhance osteogenic properties of titanium surfaces.", "datePublished": "2023-05-10", "url": "https://questionsmedicales.fr/article/37173196", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.dental.2023.05.004" } }, { "@type": "ScholarlyArticle", "name": "Potential Association of Doxycycline With the Onset of Primary Sclerosing Cholangitis: A Case Series.", "datePublished": "2022-07-01", "url": "https://questionsmedicales.fr/article/31567143", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/MJT.0000000000001065" } }, { "@type": "ScholarlyArticle", "name": "In vitro combination with doxycycline plus antifungals against clinical Mucorales pathogens.", "datePublished": "2023-11-07", "url": "https://questionsmedicales.fr/article/37934403", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s42770-023-01167-z" } }, { "@type": "ScholarlyArticle", "name": "Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study.", "datePublished": "2023-05-31", "url": "https://questionsmedicales.fr/article/37257466", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1055/s-0043-1768668" } }, { "@type": "ScholarlyArticle", "name": "Effect of the Matrix Metalloproteinase Inhibitor Doxycycline on Human Trace Fear Memory.", "datePublished": "2023-02-24", "url": "https://questionsmedicales.fr/article/36759188", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1523/ENEURO.0243-22.2023" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérocycliques 3 noyaux", "item": "https://questionsmedicales.fr/mesh/D006575" }, { "@type": "ListItem", "position": 5, "name": "Acridines", "item": "https://questionsmedicales.fr/mesh/D000166" }, { "@type": "ListItem", "position": 6, "name": "Aminoacridines", "item": "https://questionsmedicales.fr/mesh/D000609" }, { "@type": "ListItem", "position": 7, "name": "Mépacrine", "item": "https://questionsmedicales.fr/mesh/D011796" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Mépacrine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Mépacrine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-02", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Mépacrine", "description": "Comment diagnostiquer une infection nécessitant la mépacrine ?\nQuels tests sont utilisés pour la mépacrine ?\nLa mépacrine est-elle utilisée pour des maladies spécifiques ?\nQuels symptômes indiquent un besoin de mépacrine ?\nComment évaluer l'efficacité de la mépacrine ?", "url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Doxycycline&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Mépacrine", "description": "Quels sont les effets secondaires courants de la mépacrine ?\nLa mépacrine peut-elle provoquer des réactions allergiques ?\nQuels symptômes indiquent une surdose de mépacrine ?\nLa mépacrine affecte-t-elle le système digestif ?\nQuels signes d'infection nécessitent un traitement par mépacrine ?", "url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Doxycycline&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Mépacrine", "description": "Comment prévenir les infections traitées par mépacrine ?\nLes voyages dans certaines zones augmentent-ils le risque d'infection ?\nDes vaccins existent-ils pour prévenir les infections ?\nComment réduire le risque de piqûres de moustiques ?\nLa mépacrine peut-elle être utilisée en prévention ?", "url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Doxycycline&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Mépacrine", "description": "Comment la mépacrine est-elle administrée ?\nQuelle est la posologie standard de mépacrine ?\nLa mépacrine est-elle efficace contre tous les parasites ?\nPeut-on combiner la mépacrine avec d'autres traitements ?\nQuels sont les traitements alternatifs à la mépacrine ?", "url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Doxycycline&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Mépacrine", "description": "Quelles complications peuvent survenir avec la mépacrine ?\nLa mépacrine peut-elle causer des problèmes hématologiques ?\nQuels signes indiquent une complication grave ?\nComment gérer les complications liées à la mépacrine ?\nLes complications sont-elles fréquentes avec la mépacrine ?", "url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Doxycycline&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Mépacrine", "description": "Quels facteurs augmentent le risque d'infection ?\nL'âge influence-t-il le risque d'effets secondaires ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe sexe influence-t-il la réponse à la mépacrine ?\nLes interactions médicamenteuses sont-elles un risque ?", "url": "https://questionsmedicales.fr/mesh/D011796?mesh_terms=Doxycycline&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection nécessitant la mépacrine ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests de laboratoire pour identifier les parasites." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour la mépacrine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des analyses de selles peuvent être effectués." } }, { "@type": "Question", "name": "La mépacrine est-elle utilisée pour des maladies spécifiques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle est utilisée pour traiter la leishmaniose et certaines maladies auto-immunes." } }, { "@type": "Question", "name": "Quels symptômes indiquent un besoin de mépacrine ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la fièvre, des douleurs abdominales et des éruptions cutanées peuvent indiquer une infection." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité de la mépacrine ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité est évaluée par la réduction des symptômes et des résultats de tests de suivi." } }, { "@type": "Question", "name": "Quels sont les effets secondaires courants de la mépacrine ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent des nausées, des vomissements et des éruptions cutanées." } }, { "@type": "Question", "name": "La mépacrine peut-elle provoquer des réactions allergiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des réactions allergiques comme des démangeaisons ou un gonflement peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes indiquent une surdose de mépacrine ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes de surdose incluent des vertiges, des troubles de la vision et des convulsions." } }, { "@type": "Question", "name": "La mépacrine affecte-t-elle le système digestif ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut causer des troubles digestifs comme des douleurs abdominales et des diarrhées." } }, { "@type": "Question", "name": "Quels signes d'infection nécessitent un traitement par mépacrine ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des douleurs abdominales sévères et de la fièvre persistante peuvent nécessiter un traitement." } }, { "@type": "Question", "name": "Comment prévenir les infections traitées par mépacrine ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut des mesures d'hygiène, l'utilisation de moustiquaires et des vaccins." } }, { "@type": "Question", "name": "Les voyages dans certaines zones augmentent-ils le risque d'infection ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones endémiques augmente le risque d'infections parasitaires." } }, { "@type": "Question", "name": "Des vaccins existent-ils pour prévenir les infections ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Des vaccins sont disponibles pour certaines infections, mais pas pour toutes." } }, { "@type": "Question", "name": "Comment réduire le risque de piqûres de moustiques ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des répulsifs, porter des vêtements longs et installer des moustiquaires." } }, { "@type": "Question", "name": "La mépacrine peut-elle être utilisée en prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Elle n'est généralement pas utilisée en prévention, mais plutôt en traitement actif." } }, { "@type": "Question", "name": "Comment la mépacrine est-elle administrée ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "La mépacrine est généralement administrée par voie orale sous forme de comprimés." } }, { "@type": "Question", "name": "Quelle est la posologie standard de mépacrine ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La posologie varie selon l'infection, mais elle est souvent de 100 à 200 mg par jour." } }, { "@type": "Question", "name": "La mépacrine est-elle efficace contre tous les parasites ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Non, elle est principalement efficace contre certains parasites comme ceux de la leishmaniose." } }, { "@type": "Question", "name": "Peut-on combiner la mépacrine avec d'autres traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être combinée avec d'autres médicaments selon la maladie traitée." } }, { "@type": "Question", "name": "Quels sont les traitements alternatifs à la mépacrine ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des alternatives incluent l'antimoniate de méglumine et d'autres antiparasitaires." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la mépacrine ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles hépatiques et des réactions cutanées sévères." } }, { "@type": "Question", "name": "La mépacrine peut-elle causer des problèmes hématologiques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut entraîner des troubles sanguins comme l'anémie ou la thrombocytopénie." } }, { "@type": "Question", "name": "Quels signes indiquent une complication grave ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des saignements inhabituels ou des douleurs abdominales sévères doivent alerter." } }, { "@type": "Question", "name": "Comment gérer les complications liées à la mépacrine ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La gestion inclut l'arrêt du médicament et un suivi médical approprié." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes avec la mépacrine ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent survenir, nécessitant une surveillance." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'infection ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent un système immunitaire affaibli, des voyages dans des zones à risque." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque d'effets secondaires ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus sensibles aux effets secondaires de la mépacrine." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies hépatiques ou sanguines augmentent le risque." } }, { "@type": "Question", "name": "Le sexe influence-t-il la réponse à la mépacrine ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Des études montrent que le sexe peut influencer la pharmacocinétique de la mépacrine." } }, { "@type": "Question", "name": "Les interactions médicamenteuses sont-elles un risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines interactions peuvent augmenter les effets secondaires ou réduire l'efficacité." } } ] } ] }

Sources (486 au total)

Dexamethasone and doxycycline functionalized nanoparticles enhance osteogenic properties of titanium surfaces.

To evaluate the effect of doxycycline and dexamethasone doped nanoparticles covering titanium surfaces, on osteoblasts proliferation and differentiation.... Doxycycline and dexamethasone doped polymeric nanoparticles were applied on titanium discs (Ti-DoxNPs and Ti-DexNPs). Undoped NPs and uncovered Ti discs were used as control. Human MG-63 osteoblast-li... No differences in osteoblasts proliferation were found. Osteoblasts grown on Ti-DoxNPs significantly increased alkaline phosphatase activity. Doxycycline and dexamethasone nanoparticles produced an ov... DoxNPs and DexNPs were able to stimulate osteoblasts differentiation when applied on titanium surfaces, being considered potential inducers of osteogenic environment when performing regenerative proce...

Potential Association of Doxycycline With the Onset of Primary Sclerosing Cholangitis: A Case Series.

Primary sclerosing cholangitis (PSC) is linked to inflammatory bowel diseases (IBD). Evidence suggests an association between the gut microbiome and PSC. However, the putative relationship between exp... The etiopathogenesis of PSC remains an enigma.... We collected data from patients with PSC and PSC-IBD in which there seemed to be a temporal relationship between exposure to doxycycline and PSC. Time from doxycycline exposure to: (1) onset of PSC or... We identified 6 additional patients with PSC or PSC-IBD in whom there was a temporal relationship between exposure to doxycycline and onset of PSC or PSC-IBD. The median age of these 9 patients was 20... We describe 9 cases of PSC and PSC-IBD in which there seem to be a temporal relationship between exposure to doxycycline and onset of PSC....

In vitro combination with doxycycline plus antifungals against clinical Mucorales pathogens.

Since systematic antifungals for mucormycosis showed variable MICs depending on strains, effective and safe antifungal therapy was still needed. This study is aimed to evaluate the in vitro activity o... Multidrug susceptibility testing was performed with doxycycline and antifungals, including itraconazole, posaconazole, and amphotericin, in 21 isolates of 8 dominant Mucorales pathogens.... The fractional inhibitory concentration index according to M38 showed one Rhizopus arrhizus isolate synergic (∑FICI = 0.375) and other isolates in addition (0.5 < ∑FICI < 4).... Doxycycline was found to have in vitro advantages in combined antifungal treatment over antifungals alone....

Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study.

Levodopa-induced dyskinesia (LID) is a common motor complication of levodopa therapy in patients with Parkinson's disease (PD). Doxycycline is a widely used and inexpensive tetracycline with anti-infl... To evaluate the efficacy and safety of doxycycline in patients with PD and LID.... This was an open-label, uncontrolled, single-arm, single-center, phase 2 proof-of-concept study in patients with PD with functional impact of dyskinesia, which used levodopa three times daily, in a mo... Eight patients with PD were treated and evaluated. Doxycycline 200 mg/day reduced the UDysRS total score at week 12, compared with baseline (Friedman χ... In this preliminary, open-label and uncontrolled trial, doxycycline was effective in reducing LID and safe after a 12-week treatment. Further well-designed placebo-controlled clinical trials with a lo...

Doxycycline-doped collagen membranes accelerate in vitro osteoblast proliferation and differentiation.

The aim of the study was to evaluate the effect of doxycycline- and dexamethasone-doped collagen membranes on the proliferation and differentiation of osteoblasts.... Collagen barrier membranes are frequently used to promote bone regeneration and to boost this biological activity their functionalization with antibacterial and immunomodulatory substances has been su... The design included commercially available collagen membranes doped with doxycycline (Dox-Col-M) or dexamethasone (Dex-Col-M), as well as undoped membranes (Col-M) as controls, which were placed in co... Osteoblast proliferation was significantly enhanced in the functionalized membranes as follows: (Col-M < Dex-Col-M < Dox-Col-M). ALP activity was significantly higher on cultured osteoblasts on Dox-Co... The functionalization of collagen membranes with Dox promoted an increase in the proliferation and differentiation of osteoblasts....

Clinical outcomes of doxycycline, azithromycin and chloramphenicol for the treatment of patients with severe scrub typhus.

Previous studies have evaluated treatment efficacy of various antibiotics for patients with mild-to-moderate scrub typhus (ST). However, the efficacy of different antibiotics for treating severe ST re... A retrospective study of patients with severe ST was undertaken in China. The treatment efficacy rates of doxycycline, azithromycin and chloramphenicol were compared, using treatment failure and time ... In total, 876 patients with severe ST who initially received doxycycline, azithromycin or chloramphenicol were recruited. The treatment failure rate did not differ significantly between patients recei... Azithromycin and doxycycline were found to have significant therapeutic effects in patients with severe ST. In contast, chloramphenicol was less efficacious for the treatment of these patients....